Skin cancer is exploding in industrialized countries and an optimal detection is crucial for choosing the appropriate treatment. For this purpose, Dermolockin GmbH has recently developed a new thermography-based diagnostic tool allowing precise tumour margin characterization. The proposed project focuses on the development of the device algorithms and corresponding automation software, that representsa basic requiremet for a successful market entry.